Romaco purchases Innojet Herbert Hüttlin


Monday, 16 February, 2015

Manufacturing company Romaco Group has concluded the acquisition of Innojet Herbert Hüttlin. Innojet develops, designs and delivers solutions for granulating and coating solids in the pharmaceutical, food and chemical industries on the basis of an innovative product-handling concept.

Headquartered in Karlsruhe, Germany, Romaco is a global supplier of processing and packaging equipment, predominantly for the pharmaceutical industry but also for the cosmetics, food and chemical markets. The purchase of Innojet is said to make Romaco the only supplier of high-tech engineering solutions in the world with a product portfolio spanning the entire process chain for manufacturing and packing pharmaceutical solids.

Innojet will become a wholly owned company of Romaco Group under the name Romaco Innojet. Management will be shared by Paulo Alexandre (the CEO of Romaco Group), Carsten Strenger (the COO/CFO of Romaco Group) and Dr hc Herbert Hüttlin (the founder and CEO of Innojet Herbert Hüttlin), who will continue in a managerial and advisory capacity.

The Romaco Innojet management: Carsten Strenger, Christian Ott, Paulo Alexandre and Dr hc Herbert Hüttlin.

“Innojet will be able to extend its international reach enormously as a result of its integration in Romaco’s worldwide network of sales partners and agents,” said Dr hc Hüttlin. “As an equal entity within the Romaco organisation, Innojet will be optimally placed to leverage the full, unique potential of its technologies.”

“Innojet fits in perfectly with the Romaco Group’s new business model, which puts users’ specific business cases at the forefront as a starting point for totally customer-focused solutions under the heading ‘Beyond Technology’,” said Alexandre.

“Thanks to the synergetic effects of our Romaco product lines - Innojet, Kilian, Noack, Siebler, Promatic and Macofar - we can serve our customers with innovative, all-in-one solutions for which there is presently no comparable alternative in the market.”

Related News

Review of R&D system a highlight of the 2024–25 Budget

Australia's science bodies have been broadly positive about the 2024–25 federal Budget...

ACRF funds three new cancer research facilities

Scientists at QIMR Berghofer, the Peter MacCallum Cancer Centre and the Bio21 Institute have...

Govt announces $1.89bn package for health and medical research

The Australian Government is investing in a "once-in-a-generation transformation of health...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd